Back to Search
Start Over
Neurofilament light chain as a biomarker for monitoring response to change in treatment in hereditary ATTR amyloidosis.
- Source :
- Amyloid; Sep2023, Vol. 30 Issue 3, p351-352, 2p
- Publication Year :
- 2023
-
Abstract
- In this analysis, we evaluated the value of NfL in monitoring treatment response in patients with ATTRv amyloidosis with polyneuropathy whose treatment was switched from tafamidis to patisiran. Hereditary ATTR (ATTRv) amyloidosis is a fatal autosomal dominant disorder in which variants in the I transthyretin (TTR) i gene cause systemic deposition of amyloid fibrils. [Extracted from the article]
- Subjects :
- CARDIAC amyloidosis
CYTOPLASMIC filaments
AMYLOIDOSIS
PERIPHERAL neuropathy
Subjects
Details
- Language :
- English
- ISSN :
- 13506129
- Volume :
- 30
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- Amyloid
- Publication Type :
- Academic Journal
- Accession number :
- 170393484
- Full Text :
- https://doi.org/10.1080/13506129.2023.2187678